Parachute mitral valve

From WikiMD's WELLNESSPEDIA

Parachute mitral valve is a rare congenital heart defect characterized by the abnormal development of the mitral valve in which all the chordae tendineae are attached to a single papillary muscle. This condition can lead to mitral valve stenosis and other complications.

Anatomy and Pathophysiology[edit]

In a normal heart, the mitral valve has two papillary muscles that anchor the chordae tendineae, which in turn attach to the valve leaflets. In a parachute mitral valve, all the chordae tendineae are connected to a single papillary muscle, resembling a parachute. This abnormality can cause restricted movement of the valve leaflets, leading to mitral valve stenosis.

Clinical Presentation[edit]

Patients with a parachute mitral valve may present with symptoms of heart failure, such as dyspnea, fatigue, and palpitations. The severity of symptoms often depends on the degree of mitral valve obstruction.

Diagnosis[edit]

The diagnosis of a parachute mitral valve is typically made using echocardiography, which can visualize the abnormal attachment of the chordae tendineae to a single papillary muscle. Additional imaging techniques, such as cardiac MRI or CT scan, may be used to further assess the anatomy and function of the mitral valve.

Treatment[edit]

Treatment options for a parachute mitral valve depend on the severity of the condition. Mild cases may be managed with medical therapy to control symptoms of heart failure. Severe cases may require surgical intervention, such as mitral valve repair or mitral valve replacement.

Prognosis[edit]

The prognosis for individuals with a parachute mitral valve varies based on the severity of the condition and the presence of other congenital heart defects. Early diagnosis and appropriate management are crucial for improving outcomes.

See Also[edit]

References[edit]


External Links[edit]





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.